Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 1997

View Archived Issues

New agent for breast cancer in development at Zenyaku Kogyo

Oxygen carrier tested in patients with sickle cell disease

AmBisome approved in Russia

Fujisawa Foundation gives research grants

HemoCleanse submits 510(k) for ThermoChem-HT

R&D partnership announced between Helix BioPharma and PENCE

DiagnoCure granted U.S. patent for nanoerythrosomes

Patent for dry powder inhaler issued to TheraTech

CytoGam approved for marketing in Canada

Texas Biotechnology and SmithKline Beecham form marketing alliance for Novastan

IL-1ra tested for corneal transplant

YH-439 metabolites identified in rat urine

Labopharm: Q1 1997 highlights

Pain management: How to take control

DaunoXome approved in Russia

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Results of RPR Gencell's gene therapy for Parkinson's disease reported

AVE seeks FDA approval for stent products

New analgesic/antiinflammatory compounds from Korea

First launch for new angiotensin II blocker

NMDA antagonist enters phase I for epilepsy

Atypical beta-adrenoceptor agonists from Glaxo Wellcome

Transkaryotic Therapies allowed European patent for gene therapy technology

Algos and NIDA enter into collaboration for heroin addiction treatment

Seragen grants U.S. Surgical option to restenosis product

Shionogi's beta-lactam antibiotic launched in Japan

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...